Диссертация (Способы коррекции ранних механизмов канцерогенеза в органах репродуктивной системы), страница 30

431-447.45.Abbas A., Gupta S. The Role of Histone Deacetylases in Prostate Cancer.Epigenetics. 2008; 3(6): 300–309.46.Adams J.M., Cory S. The Bcl-2 protein family: Arbiters of cell survival.Science 1998; 281:1322–1326.47.Adewuyi S. A., Zayyan M. S., Onwuhafua P. I., M. Samaila O. A.,Rafindadi A. H., Oguntayo A. O. Long survival in patients with metastaticleiomyosarcoma of the uterine corpus: A report of 2 cases Journal ofCancer Research and Experimental Oncology 2010; Vol. 2(2), pp.

23-26.18548.Ahmad N., Gupta S., Mukhtar H. Green tea polyphenol epigallocatechin3-gallate differentially modulates nuclear factor kappaB in cancer cellsversus normal cells. Arch Biochem Biophys. 2000; 376(2):338-46.49.Allis C.D., Jenuwein T., Reinberg D. Overview and Concepts. InEpigenetics; John Inglis: New York, NY, USA, 2007; pp. 23–61.50.Andrianova E., Paltsev M., Kiselev V., Drukh V., Muyzhnek E.,Kuznetsov I. Study to Assess Safety and Tolerability of thePharmaceutical Composition Based on Diindolylmethane in Patientswith Endometrial Hyperplasia without Atypia. Biology and Medicine.2015, 7:4.51.Ashrafian L., Sukhikh G., Kiselev V., Paltsev M., Drukh V., KuznetsovI., Muyzhnek E., Apolikhina I., Andrianova E.

Double-blind randomizedplacebocontrolledmulticenterclinicaltrial(phaseIIa)ondiindolylmethane’s efficacy and safety in the treatment of CIN:implications for cervical cancer prevention. The EPMA Journal 2015,6:25.52.Assoian R.K., Zhu X. Cell anchorage and the cytoskeleton as partners ingrowth factor dependent cell cycle progression. Curr. Opin. Cell Biol.1997; 9, 93.53.Athanassiadou P., Athanassiades P, Grapsa D, Gonidi M, AthanassiadouAM, Stamati PN, Patsouris E. The prognostic value of PTEN, p53, andbeta-catenininendometrialcarcinoma:aprospectiveimmunocytochemical study.

Int J Gynecol Cancer. 2007; 17(3):697-704.54.Auborn K., Abramson A., Bradlow H., Sepkovic D.W., Mullolly V.Estrogen metabolism and respiratory papillomatosis: A pilot study ondietary prevention. Anticancer Res 1998; 18:4569-4574.55.Auborn K.J., Woodworth C., DiPaolo J.A., Bradlow H.L. The interactionbetween HPV infection and estrogen metabolism in cervicalcarcinogenesis. Int J Cancer.

1991; 49(6):867–9.18656.Auger C., Mullen W., Hara Y., Crozier A. Bioavailability of polyphenonE flavan-3-ols in humans with an ileostomy. J Nutr. 2008Aug;138(8):1535S-1542S.57.Bae I., Fan S., Meng Q., et al. BRCA1 induces antioxidant geneexpression and resistance to oxidative stress. Cancer Res 2004; 64:7893–7909.58.Balasubramanian S., Verner E., Buggy J.J. (2009) Isoform-specifichistone deacetylase inhibitors: the next step? Cancer Lett., 280, 211-221.59.Bao S., Cao Y., Zhou H., Sun X., Shan Z., Teng W.

Epigallocatechingallate (EGCG) suppresses lipopolysaccharide-induced Toll-likereceptor 4 (TLR4) activity via 67 kDa laminin receptor (67LR) in 3T3L1 adipocytes. J Agric Food Chem. 2015; 63(10):2811-9.60.Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian andbreast cancer in women with polycystic ovary syndrome: a systematicreview and meta-analysis. Hum Reprod Update.

2014; 20(5):748-58.61.Baylin S.B., Ohm J.E. Epigenetic gene silencing in cancer - a mechanismfor early oncogenic pathway addiction? Nat. Rev. Cancer, 6 (2006), pp.107–116;62.Beaver L.M., Yu T.W., Sokolowski E.I. et al. (2012) 3,3’Diindolylmethane,butnotindole-3-carbinol,inhibitshistonedeacetylase activity in prostate cancer cells. Toxicol.

Appl. Pharmacol.,263(3), 345-351.63.Benavides F., Blando J., Perez C. J., Garg R., Conti C. J., DiGiovanni J.,Kazanietz M. G. Transgenic overexpression of PKCε in the mouseprostate induces preneoplastic lesions. Cell Cycle. 2011; 10(2): 268–277.64.Berletch J. B., Liu C., Love W. K., Andrews L. G., Katiyar S. K.,Tollefsbol T. O. Epigenetic and genetic mechanisms contribute totelomerase inhibition by EGCG. Journal of Cellular Biochemistry 2008;103, 509-519.18765.Bernadino J, Roux C, Almeida A, Vogt N, Gibaud A, Gerbault-SeureauM, et al.

DNA hypomethylation in breast cancer: an independentparameter of tumor progression? Cancer Genet Cytogenet. 1997; 97:83–89.66.Bernard-Gallon D.J., De Latour M.P., Sylvain V., Vissac C., AunobleB., Chassagne J., Bignon Y.J. Brca1 and Brca2 protein expressionpatterns in different tissues of murine origin.

Int J Oncol. 2001; 18:271–280.67.Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., Corti A.Chemoprevention of human prostate cancer by oral administration ofgreen tea catechins in volunteers with high-grade prostate intraepithelialneoplasia: a preliminary report from a one-year proof-of-principle study,Cancer Res.

66 (2006) 1234–1240.68.Bhowmik A., Das N., Pal U., Mandal M., Bhattacharya S., Sarkar M.,JaisankarP.,MaitiN.C.,GhoshM.K.2,2'-diphenyl-3,3'-diindolylmethane: a potent compound induces apoptosis in breast cancercells by inhibiting EGFR pathway. PLoS One. 2013; 8(3):e59798.69.Bishop K. S., Ferguson L. R. The Interaction between Epigenetics,Nutrition and the Development of Cancer. Nutrients 2015, 7(2), 922-947.70.Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL.

Extensiverepeat transrectal ultrasound guided prostate biopsy in patients withprevious benign sextant biopsies. J Urol. 2000; 163:158–162.71.Bortner D.M., Rosenberg M.P. Induction of mammary gland hyperplasiaand carcinomas in transgenic mice expressing human cyclin E. Mol CellBiol. 1997; 17(1):453-9.72.Bosviel R., Michard E., Lavediaux G., Kwiatkowski F., Bignon Y.J.,Bernard-Gallon D.J. Peripheral blood DNA methylation detected in theBRCA1 or BRCA2 promoter for sporadic ovarian cancer patients andcontrols. Clin Chim Acta. 2011;412:1472–1475.18873.Brennan K, Garcia-Closas M, Orr N, Fletcher O, Jones M, Ashworth A,Swerdlow A, Thorne H, et al. Intragenic ATM methylation in peripheralblood DNA as a biomarker of breast cancer risk.

Cancer Res. 2012;72(9):2304-13.74.Brinton L.A., Sakoda L.C., Sherman M.E., Frederiksen K., Kjaer S.K.,Graubard B.I., Olsen J.H., Mellemkjaer L. Relationship of benigngynecologic diseases to subsequent risk of ovarian and uterine tumors.Cancer Epidemiol Biomarkers Prev. 2005; 14(12):2929-35.75.Brozek I., Ochman K., Debniak J., Morzuch L., Ratajska M.,Stepnowska M., Stukan M., Emerich J., Limon J. Loss of heterozygosityat BRCA1/2 loci in hereditary and sporadic ovarian cancers. J ApplGenet. 2009; 50(4):379-84.76.Burotto M., Chiou VL, Lee JM, Kohn EC. The MAPK pathway acrossdifferent malignancies: a new perspective. Cancer. 2014; 120(22):344656.77.Busbee P.B., Nagarkatti M., Nagarkatti P.S.

Natural indoles, indole-3carbinol and 3,3'-diindolymethane, inhibit T cell activation bystaphylococcal enterotoxin B through epigenetic regulation involvingHDAC expression. Toxicol Appl Pharmacol. 2014; 274(1):7-16.78.Campeau P.M., Foulkes W.D., Tischkowitz M.D. Hereditary breastcancer: New genetic developments, new therapeutic avenues. HumanGenetics 2008; 124(1):31–42.79.Carruba G.

Estrogen and prostate cancer: an eclipsed truth in anandrogen-dominated scenario. J Cell Biochem. 2007; 102(4):899-911.80.Carter T.H., Liu K., Ralph W., Chen D., Qi M., Fan S., et al.Diindolylmethane alters gene expression in human keratinocytes in vitro.J Nutr. 2002; 132(11):3314–24.81.Castañon A., Tristram A., Mesher D., Powell N., Beer H., Ashman S.,Rieck G., Fielder H., Fiander A., Sasieni P. Effect of diindolylmethane189supplementation on low-grade cervical cytological abnormalities:double-blind, randomised, controlled trial.

Br J Cancer. 2012; 106(1):4552.82.Cavalieri E.L., Rogan E.G. A unified mechanism in the initiation ofcancer. Ann N Y Acad Sci. 2002; 959: 341–354.83.Chaffer C.L., Brueckmann I., Scheel C., Kaestli A.J., Wiggins P.A.,Rodrigues L.O., Brooks M., Reinhardt F., Su Y., Polyak K., ArendtL.M., Kuperwasser C., Bierie B., Weinberg R.A. Normal and neoplasticnonstem cells can spontaneously convert to a stem-like state. Proc NatlAcad Sci USA. 2011; 108(19):7950-5.84.Chen C., Doherty J.A., Lewis S.K., Ray R.M., Gao D.L., Stalsberg H.,Feng Z., Thomas D.B. Insulin-like growth factor-I, insulin-like growthfactor binding protein-3 and the risk of fibrocystic breast conditionsamong Chinese women.

Int J Cancer. 2006; 118(9):2303-9.85.Chen D., Banerjee S., Cui Q.C., Kong D., Sarkar F.H., Dou Q.P.Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane(DIM) is associated with human prostate cancer cell death in vitro and invivo. PLoS One. 2012; 7(10):e47186.86.Chen H., Yao K., Chang X., Shim J.H., Kim H.G., Malakhova M., KimD.J., Bode A.M., Dong Z. Computational and Biochemical Discovery ofRSK2 as a Novel Target for Epigallocatechin Gallate (EGCG). PLoSOne. 2015; 10(6):e0130049.87.Chen Z.P., Schell J.B., Ho C.T., Chen K.Y.